TNFR2: A Novel Target for Cancer Immunotherapy
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Molecular Medicine
Reference80 articles.
1. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J. Clin. Oncol.,1998
2. US Food and Drug Administration. FDA Hematology/Oncology (Cancer) Approvals & Safety Notifications. https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm279174.htm
3. Regulatory circuits of T cell function in cancer;Speiser;Nat. Rev. Immunol.,2016
4. T-regulatory cells: key players in tumor immune escape and angiogenesis;Facciabene;Cancer Res.,2012
5. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells;Chen;J. Immunol.,2007
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting TNFR2 for cancer immunotherapy: recent advances and future directions;Journal of Translational Medicine;2024-09-02
2. The implications of the TNFα‐TNFR2 immune checkpoint signaling pathway in cancer treatment: From immunoregulation to angiogenesis;International Journal of Cancer;2024-08-14
3. Tumor Necrosis Factor Receptor-2 Signals Clear-Cell Renal Carcinoma Proliferation via Phosphorylated 4E Binding Protein-1 and Mitochondrial Gene Translation;The American Journal of Pathology;2024-07
4. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07
5. Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer;Journal of Advanced Research;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3